Detailed information for compound 625437

Basic information

Technical information
  • TDR Targets ID: 625437
  • Name: 2-(1-methylimidazol-2-yl)sulfanyl-1-(4-methyl phenyl)ethanone
  • MW: 246.328 | Formula: C13H14N2OS
  • H donors: 0 H acceptors: 2 LogP: 2.63 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)C(=O)CSc1nccn1C
  • InChi: 1S/C13H14N2OS/c1-10-3-5-11(6-4-10)12(16)9-17-13-14-7-8-15(13)2/h3-8H,9H2,1-2H3
  • InChiKey: GNNBSOAZCBHUEU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[(1-methyl-2-imidazolyl)thio]-1-(4-methylphenyl)ethanone
  • 2-[(1-methylimidazol-2-yl)thio]-1-(4-methylphenyl)ethanone
  • ZINC01506452

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0116 0.7773 1
Trypanosoma brucei proteasome subunit beta type-2, putative 0.0027 0.1154 0.2786
Plasmodium vivax proteasome subunit beta type-2, putative 0.0027 0.1154 0.2786
Leishmania major proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative 0.0044 0.2396 0.6897
Plasmodium falciparum proteasome subunit beta type-2, putative 0.0027 0.1154 0.2786
Plasmodium vivax proteasome subunit beta type-1, putative 0.0044 0.2396 0.6897
Giardia lamblia Proteasome subunit beta type 1 0.0044 0.2396 0.6897
Echinococcus multilocularis proteasome (prosome, macropain) subunit, beta 0.0044 0.2396 0.6897
Giardia lamblia Proteasome subunit beta type 5 precursor 0.0056 0.3333 1
Echinococcus granulosus thioredoxin glutathione reductase 0.0046 0.254 0.7376
Trypanosoma brucei proteasome beta 6 subunit 0.0044 0.2396 0.6897
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0104 0.6906 0.8837
Plasmodium falciparum thioredoxin reductase 0.0046 0.254 0.7376
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0016 0.0313 0.5
Toxoplasma gondii proteasome subunit beta type 2, putative 0.0027 0.1154 0.2786
Schistosoma mansoni proteasome catalytic subunit 3 (T01 family) 0.0056 0.3333 0.3117
Plasmodium vivax thioredoxin reductase, putative 0.0046 0.254 0.7376
Trypanosoma cruzi trypanothione reductase, putative 0.0046 0.254 0.7376
Plasmodium falciparum proteasome subunit beta type-1, putative 0.0044 0.2396 0.6897
Echinococcus granulosus proteasome prosome macropain 0.0056 0.3333 1
Leishmania major proteasome beta 5 subunit, putative 0.0056 0.3333 1
Loa Loa (eye worm) glutathione reductase 0.0046 0.254 0.6362
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.0027 0.1154 0.2786
Mycobacterium tuberculosis Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. 0.0056 0.3333 0.4047
Toxoplasma gondii proteasome subunit beta type, putative 0.0056 0.3333 1
Trypanosoma cruzi proteasome beta 6 subunit, putative 0.0044 0.2396 0.6897
Brugia malayi proteasome subunit beta type 2 0.0027 0.1154 0.3464
Mycobacterium tuberculosis Probable dehydrogenase 0.0104 0.6906 0.8837
Plasmodium falciparum proteasome subunit beta type-5 0.0056 0.3333 1
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0104 0.6906 0.8837
Trypanosoma brucei proteasome subunit beta type-5, putative 0.0056 0.3333 1
Loa Loa (eye worm) proteasome subunit beta type 1 0.0044 0.2396 0.5699
Trypanosoma brucei trypanothione reductase 0.0046 0.254 0.7376
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.0056 0.3333 1
Toxoplasma gondii proteasome subunit beta type 1, putative 0.0044 0.2396 0.6897
Loa Loa (eye worm) proteasome A-type and B-type family protein 0.0056 0.3333 1
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0046 0.254 0.2985
Treponema pallidum NADH oxidase 0.0016 0.0313 0.5
Echinococcus granulosus proteasome prosome macropain subunit beta 0.0027 0.1154 0.2786
Brugia malayi glutathione reductase 0.0046 0.254 0.7622
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.0044 0.2396 0.6897
Toxoplasma gondii thioredoxin reductase 0.0046 0.254 0.7376
Echinococcus multilocularis thioredoxin glutathione reductase 0.0046 0.254 0.7376
Mycobacterium tuberculosis Probable reductase 0.0104 0.6906 0.8837
Plasmodium vivax glutathione reductase, putative 0.0046 0.254 0.7376
Plasmodium vivax proteasome subunit beta type-5, putative 0.0056 0.3333 1
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0104 0.6906 0.8837
Schistosoma mansoni proteasome subunit beta 1 (T01 family) 0.0044 0.2396 0.215
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0016 0.0313 0.0941
Mycobacterium leprae PROBABLE NADH DEHYDROGENASE NDH 0.0104 0.6906 0.8047
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0016 0.0313 0.5
Leishmania major trypanothione reductase 0.0046 0.254 0.7376
Brugia malayi proteasome subunit beta type 1 0.0044 0.2396 0.7189
Mycobacterium ulcerans proteasome PrcB 0.0056 0.3333 1
Echinococcus multilocularis proteasome (prosome, macropain) 0.0056 0.3333 1
Echinococcus granulosus proteasome prosome macropain subunit beta 0.0044 0.2396 0.6897
Schistosoma mansoni proteasome subunit beta 2 (T01 family) 0.0027 0.1154 0.0868
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0116 0.7773 1
Giardia lamblia Proteasome subunit beta type 2 0.0027 0.1154 0.2786
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0016 0.0313 0.5
Brugia malayi Thioredoxin reductase 0.0046 0.254 0.7622
Echinococcus multilocularis proteasome (prosome, macropain) subunit, beta 0.0027 0.1154 0.2786
Plasmodium falciparum glutathione reductase 0.0046 0.254 0.7376
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.0027 0.1154 0.2786
Trypanosoma cruzi proteasome subunit beta type-2, putative 0.0027 0.1154 0.2786
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.0056 0.3333 1
Trypanosoma cruzi 20S proteasome subunit 0.0027 0.1154 0.2786
Entamoeba histolytica proteasome subunit beta type 5 precursor, putative 0.0056 0.3333 1
Loa Loa (eye worm) thioredoxin reductase 0.0046 0.254 0.6362
Brugia malayi Proteasome A-type and B-type family protein 0.0056 0.3333 1
Schistosoma mansoni proteasome subunit beta 2 (T01 family) 0.0027 0.1154 0.0868
Entamoeba histolytica proteasome subunit beta type 1, putative 0.0044 0.2396 0.5699
Leishmania major proteasome beta 2 subunit, putative 0.0027 0.1154 0.2786
Mycobacterium tuberculosis Probable oxidoreductase 0.0116 0.7773 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0104 0.6906 0.8837
Trypanosoma cruzi proteasome beta 6 subunit, putative 0.0044 0.2396 0.6897
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0116 0.7773 1
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.0056 0.3333 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.